1. Home
  2. |Insights
  3. |Changes to Acquisition Thresholds On the Way

Changes to Acquisition Thresholds On the Way

Client Alert | less than 1 min read | 07.29.15

On July 2, 2015, the FAR Council published a final rule, effective October 1, 2015, increasing the micro-purchase base threshold to $3,500 (from $3,000), that for use of simplified acquisition procedures for acquisition of commercial items to $7 million (from $6.5 million), the cost or pricing data threshold and the Cost Accounting Standard threshold to $750,000 (from $700,000), the prime contractor subcontracting plan floor to $700,000 (from $650,000), and the threshold for reporting first-tier subcontract information (including executive compensation) to $30,000 (from $25,000). The simplified acquisition threshold ($150,000) and the construction threshold ($1.5 million) will remain at current levels.


Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights